Skip to content

Biofeedback physical regulation of hypertension based on acupoints:a clinical trial

Biofeedback physical regulation of hypertension based on acupoints:a clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067147
Enrollment
Unknown
Registered
2022-12-28
Start date
2022-12-28
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High blood pressure

Interventions

TEAS-2Hz:TEAS-2Hz + usual care
TEAS-10Hz:TEAS-10Hz + usual care

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)SBP of 140-159 mm Hg and/or DBP of 90-99 mm Hg for individuals not taking antihypertensive drugs; SBP of 120-159 mm Hg and/or DBP of 80-99 mm Hg for individuals taking antihypertensive drugs with no change in the last month, (2)Aged 18-65 years old, male or female. (3)No hearing and comprehension disabilities to complete the questionnaires. (4)Willing to participate in clinical observation and sign written informed consent.

Exclusion criteria

Exclusion criteria: (1)Patients with secondary hypertension: such as acute and chronic glomerulonephritis, renal artery stenosis, gestational hypertensive syndrome, pheochromocytoma, primary aldosteronism, etc. (2)Contraindications to the use of electrical stimulation devices: with pacemakers or other implantable devices; suffering from acute diseases, infectious diseases and other malignant diseases; in pregnancy or lactation; breakage, inflammation, scarring, etc. at the skin of the acupuncture point; sensory impairment or allergy to electrical stimulation, etc. (3)Have taken medications other than antihypertensive drugs that may affect blood pressure, such as glucocorticoids, in the past month. (4)Have received acupuncture or transcutaneous electrical stimulation treatment in the past year.

Design outcomes

Primary

MeasureTime frame
SBP;

Secondary

MeasureTime frame
DBP;HR;HRV;MMAS-8;SF-12;MAP;

Countries

China

Contacts

Public ContactMa Liangxiao

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

maliangxiao@vip.sina.com13301188102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026